Literature DB >> 7429554

The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence.

C S Easmon, P J Cole, A J Williams, M Hastings.   

Abstract

Luminol-dependent chemiluminescence produced by peripheral blood phagocytic cells was measured using a light detecting instrument, the Luminometer 1250 (LKB Wallac). Although less sensitive than liquid scintillation counters, the Luminometer can measure chemiluminescence effectively and detect experimentally induced and clinical variations using small numbers of cells. It is small, inexpensive, simple to use and allows temperature within the reaction vial to be controlled accurately. Light emission can be recorded either graphically or by an intergrated digital printout. Luminol-dependent chemiluminescence is influenced by the presence of contaminating red blood cells and by composition of the medium, particularly presence of phenol red. HEPES buffer and foetal calf serum. Whereas clinical comparisons of opsonic activity are easily performed, comparisons of cellular activity require a high and uniform standard of cell preparation, characterization and maintenance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429554      PMCID: PMC1458226     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  Chemiluminescence response of human leukocytes: influence of medium components on light production.

Authors:  R D Nelson; M J Herron; J R Schmidtke; R L Simmons
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

3.  Use of a unique chemiluminescence spectrometer in a study of factors influencing granulocyte light emission.

Authors:  B R Andersen; A M Brendzel
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

4.  Impaired chemiluminescence during phagocytosis of opsonized bacteria.

Authors:  R L Stjernholm; R C Allen; R H Steele; W W Waring; J A Harris
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

5.  Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity.

Authors:  R C Allen; R L Stjernholm; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

6.  Chemiluminescence response of phagocytizing human monocytes.

Authors:  R D Nelson; E L Mills; R L Simmons; P G Quie
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

8.  Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors:  V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.

Authors:  P Stevens; L S Young
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.

Authors:  G E Hatch; D E Gardner; D B Menzel
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  51 in total

1.  Failure of lipopolysaccharides to directly trigger the chemiluminescence response of isolated equine polymorphonuclear leukocytes.

Authors:  H Benbarek; G Deby-Dupont; I Caudron; C Deby; M Lamy; D Serteyn
Journal:  Vet Res Commun       Date:  1997-10       Impact factor: 2.459

2.  Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies.

Authors:  M Damonneville; C Auriault; C Verwaerde; A Delanoye; R Pierce; A Capron
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Chemiluminescence response of whole blood in patients undergoing urological operations.

Authors:  M Sakumoto; T Matsumoto; O Mochida; S Kubo; Y Mizunoe; J Kumazawa
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer.

Authors:  M Torisu; Y Hayashi; T Ishimitsu; T Fujimura; K Iwasaki; M Katano; H Yamamoto; Y Kimura; M Takesue; M Kondo
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.

Authors:  M J Hastings; J Neil; C S Easmon
Journal:  Br J Exp Pathol       Date:  1985-06

6.  Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression.

Authors:  A P Weetman; M E Holt; A K Campbell; R Hall; A M McGregor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

7.  Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection.

Authors:  R Stocker; N H Hunt; I A Clark; M J Weidemann
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Effects of Pasteurella haemolytica A1 culture supernatant on mechanisms controlling bovine alveolar macrophage oxygen radical production.

Authors:  P D Conlon; P E Shewen; S F Donnelly; J P Burger
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

9.  Phagocytic activities in neonatal monocytes.

Authors:  C P Speer; M Wieland; R Ulbrich; M Gahr
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

10.  Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  N Farag; L Mahran; K Abou-Aisha; M El-Azizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-27       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.